BILATERAL RETINAL VEIN OCCLUSION ASSOCIATED WITH FACTOR V LEIDEN MUTATION

Retina ◽  
1998 ◽  
Vol 18 (4) ◽  
pp. 377 ◽  
Author(s):  
BRAD V. SPAGNOLO ◽  
FADI P. NASRALLAH
2009 ◽  
Vol 2009 ◽  
pp. 1-2 ◽  
Author(s):  
Sarwat Salim ◽  
Wai-Ching Lam ◽  
Wahid Hanna

Purpose. To describe a patient with two episodes of deep venous thrombosis and factor V Leiden mutation who presented with central retinal vein occlusion (CRVO) despite prophylactic use of warfarin sodium (Coumadin).Methods. A case report of a 44-year-old woman with a history of recurrent deep venous thrombosis and Factor V Leiden mutation was placed on lifelong prophylactic therapy with warfarin. The patient presented with CRVO in the left eye despite therapeutic levels of warfarin.Results. Extensive systemic evaluation disclosed high titers for antinuclear antibody (ANA).Conclusion. Systemic anticoagulation with warfarin may not preclude further thrombotic episodes. In younger patients presenting with retinal vein occlusion and pre-existing multiple thrombophilic risk factors, a multidisciplinary approach is recommended to explore other therapeutic options to avoid further thromboembolic complications.


1997 ◽  
Vol 77 (01) ◽  
pp. 214-216 ◽  
Author(s):  
Tuuli Linna ◽  
Antti Ylikorkala ◽  
Kimmo E Kontula ◽  
Päivi Puska ◽  
Timo Tervo

1999 ◽  
Vol 77 (6) ◽  
pp. 631-633 ◽  
Author(s):  
F. Yesim K. Demirci ◽  
Dilvin B. Guney ◽  
Koray Akarcay ◽  
Nur Kir ◽  
Ugur Ozbek ◽  
...  

2012 ◽  
Vol 32 (S 01) ◽  
pp. S95-S97
Author(s):  
H. Radtke ◽  
A. Jainz ◽  
F.-P. Schmidt ◽  
H. Kiesewetter

SummaryA protein Z deficiency is presumably related with a threefold risk of venous and arterial thrombosis. Mucosal bleedings and post-operative haematomas can occur more frequently. This is seen in an increased in vivo bleeding time without other plasmatic coagulation disorders or thrombopathies. Pregnancy complications, especially abortions before the 15th week of gestation, are described as well. Patients, methods: Since May 2011 the plasmatic concentration of protein Z has been tested in 684 patients of the Hämostaseologicum. Results: In 74 patients a protein Z deficiency has been found. In other 45 patients protein Z was reduced because of the intake of phenprocoumon or coumadin. Of the 74 patients with diminished protein Z concentration 39 were marginally decreased (protein Z 1000–1500 μg/l). Of the 35 patients with a protein Z concentration <1000 μg/l 12 had had a thrombosis before (6 strokes, 3 DVT or PE, 1 arterial thrombosis, 1 retinal branch vein occlusion, 1 acute hearing loss). 7 had arterial hypertension, 2 suffered from diabetes mellitus. Of the patients who had a thrombosis 6 had a heterozygous factor V Leiden mutation. 10 had a microcirculation disorder (Raynaud’s phenomenon), 4 had had bleeding complications before, 3 had a von Willebrand disease type I, 6 patients had had abortions and 4 were healthy. Of the 39 patients with protein Z concentrations between 1000 and 1500 μg/l 18 had experienced a thrombosis before (9 DVT or PE, 3 myocardial infarctions, 1 CHD, 3 strokes, 1 retinal branch vein occlusion, 1 PAOD I, 1 tinnitus). 5 additionally had arterial hypertension. 13 suffered from Raynaud’s phenomenon, of which 7 had a hypotension. Of the patients with thromboses 3 had a heterozygous factor V Leiden mutation and one a protein C deficiency. 7 patients had had an abortion before. Bleeding complications were seen in 4 patients, of which 3 suffered from von Willebrand disease type 1.


Sign in / Sign up

Export Citation Format

Share Document